| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/21/2013 | US20130071861 Methods and kits for detecting ita in a biological sample |
| 03/21/2013 | US20130071860 Methods for autoimmune disease diagnosis, prognosis, and treatment` |
| 03/21/2013 | US20130071859 Methods of Determining Patient Response by Measurement of HER-3 |
| 03/21/2013 | US20130071858 Automated staining system and reaction chamber |
| 03/21/2013 | US20130071857 Biomarkers Of Gastric Cancer And Use Thereof |
| 03/21/2013 | US20130071856 Method and biomarker for evaluating metastasis, and sirna compound for inhibiting metastasis |
| 03/21/2013 | US20130071855 Flc as biomarker |
| 03/21/2013 | US20130071854 Methods for the identification and characterization of hdac interacting compounds |
| 03/21/2013 | US20130071850 Waveguide-based optical scanning systems |
| 03/21/2013 | US20130071841 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 03/21/2013 | US20130071835 Qualitative and Quantitative Analytical Method for Analyzing the Activity Type of an Enzyme that is Activated by Proteolysis |
| 03/21/2013 | US20130071834 Compositions and methods useful for hcv infection |
| 03/21/2013 | US20130071424 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein |
| 03/21/2013 | US20130071421 Turkey viral hepatitis virus and uses thereof |
| 03/21/2013 | US20130071408 Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus |
| 03/21/2013 | US20130071407 Methods for modulating hematopoiesis and vascular growth |
| 03/21/2013 | US20130071404 Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
| 03/21/2013 | US20130071401 Methods of treating diabetes and compositions capable of same |
| 03/21/2013 | US20130071397 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof |
| 03/21/2013 | US20130071388 Method for treating psoriasis |
| 03/21/2013 | US20130071382 Egfr mutations |
| 03/21/2013 | US20130071302 Device and method for producing a fluidic connection between cavities |
| 03/21/2013 | US20130070230 Apparatus and method for estimating bilirubin concentration using refractometry |
| 03/21/2013 | US20130068010 Determination of Yarn Features |
| 03/21/2013 | US20130067987 High sensitivity artificial olfactory system and it's uses |
| 03/21/2013 | US20130067956 Apparatus and method for characterizing glass sheets |
| 03/21/2013 | DE112011101618T5 Verwendung von Nanoporen-Arrays zur Multiplex-Sequenzierung von Nukleinsäuren Use of nanopore arrays for multiplex sequencing of nucleic acids |
| 03/21/2013 | DE102011113943A1 Determination of hydrogen sulfide content during warm storage of sulfur-containing crude and residual oils and mineral distillate, involves dissolving sulfur-containing mineral oil sample in solvent |
| 03/21/2013 | DE102011082845A1 Messsystem und Verfahren zum Bestimmen und Regeln von flächenbezogenen Aufträgen Measurement system and method for determining and controlling of area-related contracts |
| 03/21/2013 | DE102011053758A1 Verfahren zur Untersuchung von Luft auf das Vorhandensein von biologischen Substanzen A method for the investigation of air for the presence of biological substances |
| 03/21/2013 | DE102011053741A1 Verfahren zum Überprüfen der Selbstheilung durch das Immunsystem eines mit humanen Papillomviren infizierten Menschen Method for checking the self-healing by the immune system of an infected with human papillomavirus people |
| 03/21/2013 | DE10028725B4 Primärstruktur des HNA-2a (ehemals NB1)-Antigens Primary structure of the HNA-2a (formerly NB1) antigen |
| 03/21/2013 | CA2848819A1 Antibodies directed against signal peptides, methods and uses thereof |
| 03/21/2013 | CA2848773A1 Risk predictors for adverse perinatal outcomes |
| 03/21/2013 | CA2848722A1 Means and methods for assessing gonadal toxicity |
| 03/21/2013 | CA2848614A1 An in-vitro process for the quick determination of the infection status of an infection with an influenza virus type |
| 03/21/2013 | CA2848608A1 Method and system for amplification of nucleic acids in microfluidic volume hydrogels |
| 03/21/2013 | CA2848595A1 Methods for monitoring responsiveness to anti-smad7 therapy |
| 03/21/2013 | CA2848578A1 Sperm protein as a detection biomarker of early stage ovarian cancer |
| 03/21/2013 | CA2848559A1 Method for inspecting susceptibility of bacteria or fungi to antimicrobial drug and system for use in the same |
| 03/21/2013 | CA2848403A1 Hyr1-derived compositions and methods of treatment using same |
| 03/21/2013 | CA2848366A1 Method for selection of surfactants in well stimulation |
| 03/21/2013 | CA2848365A1 Methods for prognosis of diffuse large b-cell lymphoma |
| 03/21/2013 | CA2848333A1 B7-h6 therapeutically active monoclonal antibody against b7-h6 polypeptide |
| 03/21/2013 | CA2848230A1 Endoglycosidase from streptococcus pyogenes and methods using it |
| 03/21/2013 | CA2848209A1 T cell receptors recognizing hla-a1- or hla-cw7-restricted mage |
| 03/21/2013 | CA2848162A1 Non-invasive methods of detecting target molecules |
| 03/21/2013 | CA2848043A1 Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same |
| 03/21/2013 | CA2847525A1 Neuregulin-1-based prognosis and therapeutic stratification of colorectal cancer |
| 03/21/2013 | CA2847257A1 Methods of predicting and decreasing the risk of pre-term birth |
| 03/21/2013 | CA2846887A1 Disposable sensor for electrochemical detection of hemoglobin |
| 03/21/2013 | CA2846625A1 Processes and kits to detect and monitor for diagnostic biomarkers for post traumatic stress disorder (ptsd) and to differentiate between suicidal and non-suicidal form of the disorder |
| 03/21/2013 | CA2846479A1 Method for measuring anti-wt1 antibody |
| 03/21/2013 | CA2846247A1 Molecular diagnostic assay device and method of use |
| 03/21/2013 | CA2846083A1 Methods of promoting differentiation |
| 03/21/2013 | CA2845807A1 Calibration reagent and method |
| 03/21/2013 | CA2845621A1 Means and methods for assessing hematopoietic toxicity |
| 03/21/2013 | CA2845148A1 Test tape cassette and analytical test tape therefor |
| 03/21/2013 | CA2845117A1 Means and methods for assessing kidney toxicity |
| 03/21/2013 | CA2779778A1 Unitized point-of-care urine dipstick control device |
| 03/20/2013 | EP2571086A2 Electric power generation system and gas measuring system |
| 03/20/2013 | EP2570813A2 Method for the diagnosis/prognosis of colorectal cancer |
| 03/20/2013 | EP2570812A2 Droplet actuator devices and methods employing magnetic beads |
| 03/20/2013 | EP2570811A2 Droplet actuator devices and methods employing magnetic beads |
| 03/20/2013 | EP2570810A1 Method for examination of air for the presence of biological substances by means of removable multi-well strips on which an immunological assay is performed directly |
| 03/20/2013 | EP2570809A1 Immuno-based retargeted endopeptidase activity assays |
| 03/20/2013 | EP2570808A2 Method for simulating deformation of rubber compound |
| 03/20/2013 | EP2570807A1 Method and test device for field calibration of a gas sensor |
| 03/20/2013 | EP2570800A1 Test strip cassette and analytical test strip for same |
| 03/20/2013 | EP2570798A1 Fret measurement method and fret measurement device |
| 03/20/2013 | EP2570486A1 Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor |
| 03/20/2013 | EP2570483A1 Screening method for substance having hemocyte maturation acceleration action |
| 03/20/2013 | EP2570477A1 Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) |
| 03/20/2013 | EP2570433A1 Neutralizing human antibodies to anthrax toxin generated by recall technology |
| 03/20/2013 | EP2570430A2 Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570429A2 Peptide vaccines with Seq ID No: 48, 41, 44, 46 or 78 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570428A2 Peptide vaccines with Seq ID No: 379 or 376 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570422A2 Promiscuous HER-2/NEU CD4 T cell epitopes |
| 03/20/2013 | EP2570421A1 Method to purify and concentrate prions from complex mixtures such as plasma into a target solution |
| 03/20/2013 | EP2569640A1 Biomarker |
| 03/20/2013 | EP2569639A2 Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
| 03/20/2013 | EP2569638A1 Method for the diagnosis of amyotrophic lateral sklerosis |
| 03/20/2013 | EP2569637A1 Methods for the diagnosis and prognosis of a tumor using bcat1 protein |
| 03/20/2013 | EP2569636A1 Discrete states for use as biomarkers |
| 03/20/2013 | EP2569635A1 Methods for diagnosing and treating encephalitis or epilepsy |
| 03/20/2013 | EP2569634A1 Device and method for indirect modulation of detection environment |
| 03/20/2013 | EP2569633A2 Compositions and methods of identifying tumor specific neoantigens |
| 03/20/2013 | EP2569632A1 Yeast cell wall components and detection thereof |
| 03/20/2013 | EP2569631A1 Markers for acute kidney injury |
| 03/20/2013 | EP2569630A1 Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases |
| 03/20/2013 | EP2569629A1 Detection of nicotine metabolites |
| 03/20/2013 | EP2569628A2 Method of toxicological evaluation, method of toxicological screening and associated system |
| 03/20/2013 | EP2569627A1 Systems and methods for calculating protein confidence values |
| 03/20/2013 | EP2569626A2 Methods and compositions for diagnosing conditions |
| 03/20/2013 | EP2569625A1 Method of detecting and profiling progression of the risk of neurodegenerative diseases |
| 03/20/2013 | EP2569623A1 System for measuring or monitoring the quality of a liquid medium with low energy consumption |
| 03/20/2013 | EP2569619A1 Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings |
| 03/20/2013 | EP2569612A2 Method and apparatus for determining the coke generation tendency of hydrocarbons |
| 03/20/2013 | EP2569611A1 Vessel outgassing inspection methods |
| 03/20/2013 | EP2569605A1 Multiphase flowmeter with batch separation |